drugset / Trial / NCT00172094
Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study was to evaluate the effectiveness and safety of a single oral dose of NPS 1776 in the acute treatment of migraine pain and associated symptoms.
Timeline
- Start
- 2003-12-31
- Primary completion
- 2004-06-30
- Completion
- 2004-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | isovaleramide | Small molecule | 400 mg | Oral |
| Subject | isovaleramide | Small molecule | 800 mg | Oral |